These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 12387455)

  • 1. Mutational and expression analysis of the NF1 gene argues against a role as tumor suppressor in sporadic pilocytic astrocytomas.
    Wimmer K; Eckart M; Meyer-Puttlitz B; Fonatsch C; Pietsch T
    J Neuropathol Exp Neurol; 2002 Oct; 61(10):896-902. PubMed ID: 12387455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of NF1 alleles distinguish sporadic from NF1-associated pilocytic astrocytomas.
    Kluwe L; Hagel C; Tatagiba M; Thomas S; Stavrou D; Ostertag H; von Deimling A; Mautner VF
    J Neuropathol Exp Neurol; 2001 Sep; 60(9):917-20. PubMed ID: 11556548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of specific NF 1 gene transcripts in sporadic pilocytic astrocytomas.
    Platten M; Giordano MJ; Dirven CM; Gutmann DH; Louis DN
    Am J Pathol; 1996 Aug; 149(2):621-7. PubMed ID: 8702000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of neurofibromatosis 1 (NF1) gene expression in NF1-associated pilocytic astrocytomas.
    Gutmann DH; Donahoe J; Brown T; James CD; Perry A
    Neuropathol Appl Neurobiol; 2000 Aug; 26(4):361-7. PubMed ID: 10931370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletions on the long arm of chromosome 17 in pilocytic astrocytoma.
    von Deimling A; Louis DN; Menon AG; von Ammon K; Petersen I; Ellison D; Wiestler OD; Seizinger BR
    Acta Neuropathol; 1993; 86(1):81-5. PubMed ID: 8103960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic neurofibromatosis type 1 (NF1) inactivation characterizes NF1-associated pilocytic astrocytoma.
    Gutmann DH; McLellan MD; Hussain I; Wallis JW; Fulton LL; Fulton RS; Magrini V; Demeter R; Wylie T; Kandoth C; Leonard JR; Guha A; Miller CA; Ding L; Mardis ER
    Genome Res; 2013 Mar; 23(3):431-9. PubMed ID: 23222849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis of astrocytomas presenting after age 10 in individuals with NF1.
    Gutmann DH; James CD; Poyhonen M; Louis DN; Ferner R; Guha A; Hariharan S; Viskochil D; Perry A
    Neurology; 2003 Nov; 61(10):1397-400. PubMed ID: 14638962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of neurofibromin is associated with activation of RAS/MAPK and PI3-K/AKT signaling in a neurofibromatosis 1 astrocytoma.
    Lau N; Feldkamp MM; Roncari L; Loehr AH; Shannon P; Gutmann DH; Guha A
    J Neuropathol Exp Neurol; 2000 Sep; 59(9):759-67. PubMed ID: 11005256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-related gene expression profiles in NF1-associated pilocytic astrocytomas.
    Li J; Perry A; James CD; Gutmann DH
    Neurology; 2001 Apr; 56(7):885-90. PubMed ID: 11294925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilocytic astrocytomas do not show most of the genetic changes commonly seen in diffuse astrocytomas.
    Cheng Y; Pang JC; Ng HK; Ding M; Zhang SF; Zheng J; Liu DG; Poon WS
    Histopathology; 2000 Nov; 37(5):437-44. PubMed ID: 11119125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of p53 gene mutations in a tumor panel representative of pilocytic astrocytoma diversity using a p53 functional assay.
    Ishii N; Sawamura Y; Tada M; Daub DM; Janzer RC; Meagher-Villemure M; de Tribolet N; Van Meir EG
    Int J Cancer; 1998 Jun; 76(6):797-800. PubMed ID: 9626343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic variations in NF1-associated low grade astrocytomas: possible role for increased mTOR activation in a subset.
    Jentoft M; Giannini C; Cen L; Scheithauer BW; Hoesley B; Sarkaria JN; Abell-Aleff PC; Rodriguez EF; Li Y; Rodriguez FJ
    Int J Clin Exp Pathol; 2010 Dec; 4(1):43-57. PubMed ID: 21228927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects.
    Reilly KM; Loisel DA; Bronson RT; McLaughlin ME; Jacks T
    Nat Genet; 2000 Sep; 26(1):109-13. PubMed ID: 10973261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered expression of immune defense genes in pilocytic astrocytomas.
    Huang H; Hara A; Homma T; Yonekawa Y; Ohgaki H
    J Neuropathol Exp Neurol; 2005 Oct; 64(10):891-901. PubMed ID: 16215461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary observations on genetic alterations in pilocytic astrocytomas associated with neurofibromatosis 1.
    Tada K; Kochi M; Saya H; Kuratsu J; Shiraishi S; Kamiryo T; Shinojima N; Ushio Y
    Neuro Oncol; 2003 Oct; 5(4):228-34. PubMed ID: 14565158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No aberrant methylation of neurofibromatosis 1 gene (NF1) promoter in pilocytic astrocytoma in childhood.
    Ebinger M; Senf L; Wachowski O; Scheurlen W
    Pediatr Hematol Oncol; 2005; 22(1):83-7. PubMed ID: 15770836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis at the NF1 locus in astrocytic brain tumors.
    Jensen S; Paderanga DC; Chen P; Olson K; Edwards M; Iavorone A; Israel MA; Shannon K
    Cancer; 1995 Aug; 76(4):674-7. PubMed ID: 8625164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 gene mutations in human astrocytic brain tumors including pilocytic astrocytomas.
    Patt S; Gries H; Giraldo M; Cervos-Navarro J; Martin H; Jänisch W; Brockmöller J
    Hum Pathol; 1996 Jun; 27(6):586-9. PubMed ID: 8666369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular and cell biology of pediatric low-grade gliomas.
    Chen YH; Gutmann DH
    Oncogene; 2014 Apr; 33(16):2019-26. PubMed ID: 23624918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of the tumor suppressor A-kinase anchor protein 12 in human diffuse and pilocytic astrocytomas is regulated by promoter methylation.
    Goeppert B; Schmidt CR; Geiselhart L; Dutruel C; Capper D; Renner M; Vogel MN; Zachskorn C; Zinke J; Campos B; Schmezer P; Popanda O; Wick W; Weller M; Meyermann R; Schittenhelm J; Harter PN; Simon P; Weichert W; Schirmacher P; Plass C; Mittelbronn M
    J Neuropathol Exp Neurol; 2013 Oct; 72(10):933-41. PubMed ID: 24042196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.